Curis Competitors and Similar CompaniesClear all
Curis's competitors and similar companies include Intrepida Bio, MaxiVAX and Verseau Therapeutics.
 Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. |  Intrepida Bio Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. |  MaxiVAX MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. |  Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. | |
Founding Date | Founding Date 2000 | Founding Date 2019 | Founding Date 2013 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Lexington, US HQ Lexington, US | Locations San Diego, US HQ | Locations Genève, CH HQ Genève, CH | Locations Bedford, US HQ |
Employees | Employees 3144% decrease | Employees N/A | Employees 5 | Employees 6 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 9.5m (over 6 years ago) | Latest funding round $ 5m (over 6 years ago) | Latest funding round $ 50m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 9.5m | Total funding raised $ 8.1m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Intrepida Bio
HQ
San Diego, US
Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases.
View companyMaxiVAX
HQ
Genève, CH
Employees
5
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.
View companyVerseau Therapeutics
HQ
Bedford, US
Employees
6
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
View company